Metabolic Health India

Interesting video. Please check it out

T2 DIABETES REMISSION FOREVER CO-MORBIDITY FREE T2 DIABETES IN REMISION FOR 10 YEARS!!! Dr Rob Cywes, Carbaddictiondoc, has a “how I did it” conversation with Shashi Iyengar who has kept ...

Indians with Type 2 Diabetes - this is for you.

A 10-year remission without medications, using a practical Indian low-carb approach.

This is not theory - it is published, real-world data tracked over a decade.

We discuss what actually worked, what failed, and what can be sustained long term.

If you are tired of rising sugars and medications, this will make you rethink your approach.

Dr. Robert Cywes in conversation with Shashikant Iyengar on this 10-year published diabetes remission study

T2 DIABETES REMISSION FOREVER CO-MORBIDITY FREE T2 DIABETES IN REMISION FOR 10 YEARS!!! Dr Rob Cywes, Carbaddictiondoc, has a “how I did it” conversation with Shashi Iyengar who has kept ...

Indians with Type 2 Diabetes - this is for you.

A 10-year remission without medications, using a practical Indian low-carb approach.

This is not theory - it is published, real-world data tracked over a decade.

We discuss what actually worked, what failed, and what can be sustained long term.

If you are tired of rising sugars and medications, this will make you rethink your approach.

Dr. Robert Cywes in conversation with Shashikant Iyengar on this 10-year published diabetes remission study.

T2 DIABETES REMISSION FOREVER CO-MORBIDITY FREE T2 DIABETES IN REMISION FOR 10 YEARS!!! Dr Rob Cywes, Carbaddictiondoc, has a “how I did it” conversation with Shashi Iyengar who has kept ...

🚨 Just Released: 10 Years of T2D Remission! 🚨

It is now part of the scientific record.

The study documents medication-free remission over a decade, achieved using a low-carbohydrate, lacto-ovo vegetarian diet, with systematic long-term safety evaluation.

To our knowledge, this is the first such study conducted globally.

What makes this work unique is not just remission, but rigour and duration.

For most of this period (approximately 70-75%), I followed a ketogenic diet; during the remaining time, I followed a low-carbohydrate diet with carbohydrate intake below 100 g/day.

This is a prospective N-of-1 longitudinal study, followed for a full decade, with repeated assessments across multiple domains:
•Glycaemic control (HbA1c, fasting glucose, CGM) 🩸
•Insulin dynamics 🧬
•Advanced lipids including ApoB and Lipoprotein(a)
•Inflammatory markers 🔥
•Liver and renal function (including cystatin-C)
•Serial coronary artery calcium scans 🫀
•CT coronary angiography 🫀
•Carotid imaging (CIMT)
•Bone mineral density (DEXA) 🦴
•Detailed ophthalmic imaging 👁️

Starting Hba1c was 7.2%. FBS 152 & PPBS 253 mg/dl.
Achieved remission in the 4th month with Hba1c of 5.2%

Over 10 years:
•HbA1c, FBS & PPBS remained consistently in the non-diabetic range
•Average Hba1c was 5 in 10 years. (4.7 to 5.3)
•Average LDL and ApoB remained higher than recommended, but stable
•No microvascular complications
•No macrovascular disease
•No deterioration in renal, skeletal, or ophthalmic health

This was achieved without diabetes medication.
Importantly, this is an Indian study.

The dietary pattern was:
•Low carbohydrate
•Lacto-ovo vegetarian
•Culturally adapted
•Sustained for 10 years in a South Asian individual with the MONW (Metabolically Obese Normal Weight) phenotype

This directly addresses a major gap in the literature:
the absence of long-term, real-world safety data for low-carbohydrate approaches in South Asian, predominantly vegetarian populations.

It demonstrates that:
•Long-term remission is possible
•Sustainability over a decade is possible
•Comprehensive safety monitoring is feasible
•Replication at larger scale is testable

The intent of this work is not to prescribe, but to inform, challenge existing assumptions, and invite replication.

As an N-of-1 longitudinal study, these findings are not generalizable by design.

They are hypothesis-generating and intended to inform larger, prospective cohorts.

India carries one of the highest diabetes burdens globally.

Evidence addressing sustainability must emerge from within this context.

This study is now part of the scientific record.
Big thanks to Dr Jasmeet Phd
Jasmeet Kaur whose relentless effort and scientific rigour made this study possible. She invested enormous time and care in shaping the manuscript and strengthening it to publication standard.

Grateful to my guru, Anup Singh, who introduced me to low-carb nutrition in 2015 at the time of my Type 2 diabetes diagnosis. His guidance laid the foundation for my 10-year low-carb journey.

Thank you to Arun Kumar who helped me when I was newly diagnosed.

Big Thanks to the 3 doctors who were part of my 10 years journey & are the co-authors also.

Dr Sharat Kolke MD (Med) - Physician - Criticare Asia Hosp. - Mumbai Sharat Kolke

Dr Mihir Raut - MD - Diabetologist - Nanavati Max Hosp - Mumbai Mihir Raut

Dr R K Singh MD DM (Interventional Cardiologist) - Gandhi Medical College - Bhopal RK Singh

https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1718156/full

Very low carbohydrate (ketogenic) diets in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials

A VLC/KD may cause reductions in HbA1c and triglycerides in those with pre-diabetes or T2D

Very low carbohydrate (ketogenic) diets in type 2 diabetes: a systematic review and meta‐analysis of randomised controlled trials Aim Very low carbohydrate/ketogenic diets (VLC/KDs) are popular but their role in managing pre-diabetes and Type 2 diabetes (T2D) is uncertain. This study uses a systematic review and meta-analysis ...

Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials

"each 10% reduction in carbohydrate intake reduced HbA1c, FPG and body weight"

"Carbohydrate restriction can exert a significant and important reduction on levels of cardiometabolic risk factors in patients with type 2 diabetes"

Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials - PubMed Carbohydrate restriction can exert a significant and important reduction on levels of cardiometabolic risk factors in patients with type 2 diabetes. Levels of most cardiometabolic outcomes decreased linearly with the decrease in carbohydrate intake. U-shaped effects were seen for total cholesterol a...

Back in 2019 incorporated & Very low carb in their Nutrition Therapy for silently
Now they are open about this & actually "selling" it
The credit goes to so many who pioneered it like Dr Eric Westman, Dr Tim Noakes, Dr David Unwin, Dr Sarah Hallberg etc

Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition

"A 30P:20C :50F ratio diet resulted in a 38% decrease in 24-hour glucose area, a reduction in fasting glucose to near normal and a decrease in %tGHb from 9.8% to 7.6%.
Altering the diet composition could be a patient-empowering method of improving the hyperglycemia of type 2 diabetes without weight loss or pharmacologic intervention"

Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition - Nutrition & Metabolism Background Over the past several years our research group has taken a systematic, comprehensive approach to determining the effects on body function (hormonal and non-hormonal) of varying the amounts and types of proteins, carbohydrates and fats in the diet. We have been particularly interested in t...

Effects of a six-month low-carbohydrate diet on glycemic control, body composition and cardiovascular risk factors in patients with type 2 diabetes: an open-label RCT

"A non-calorie-restricted LCD high in fat has significant beneficial effects on glycemic control and body composition, and does not adversely affect cardiovascular risk factors in patients with T2D. Reducing carbohydrate intake to 10-25 E% seems an effective and safe nutritional approach with respect to classical cardiovascular risk factors and hypoglycemia"

Effects of a six‐month low‐carbohydrate diet on glycemic control, body composition and cardiovascular risk factors in patients with type 2 diabetes: an open‐label RCT Aims To investigate the efficacy and safety of a non-calorie-restricted low-carbohydrate diet (LCD) on glycemic control, body composition, and cardiovascular risk factors in patients with type 2 dia...

A Low-Carbohydrate Diet Realizes Medication Withdrawal: A Possible Opportunity for Effective Glycemic Control

"The LCD diet can decrease body weight, glycemic levels, MES, and lipid-lowering agents more than the LFD diet, thus decreasing cost burden in Chinese patients with T2DM. Strict diet control and monitoring are the keys to managing diabetes"

A Low-Carbohydrate Diet Realizes Medication Withdrawal: A Possible Opportunity for Effective Glycemic Control ObjectiveMultiple studies have confirmed that diet restrictions can effectively realize glycemic control and reduce metabolic risks in patients with type 2 diabetes mellitus (T2DM). In 2018, the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) stated that...